Tarsus Pharmaceuticals, Inc. (TARS)
73.62
+0.81
(+1.11%)
USD |
NASDAQ |
Aug 25, 09:45
Tarsus Pharmaceuticals Price : 73.62 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 72.88 | 73.08 | 71.76 | 72.81 | 414069.0 |
| Aug 21, 2026 | 71.72 | 73.14 | 71.26 | 72.70 | 636335.0 |
| Aug 20, 2026 | 72.81 | 73.42 | 70.10 | 71.49 | 538092.0 |
| Aug 19, 2026 | 72.00 | 73.51 | 71.37 | 73.44 | 757496.0 |
| Aug 18, 2026 | 70.73 | 71.50 | 69.66 | 71.03 | 628834.0 |
| Aug 17, 2026 | 68.83 | 70.78 | 68.71 | 70.62 | 541181.0 |
| Aug 14, 2026 | 68.82 | 69.70 | 67.61 | 69.20 | 448261.0 |
| Aug 13, 2026 | 70.72 | 71.34 | 68.06 | 68.88 | 631792.0 |
| Aug 12, 2026 | 69.89 | 70.48 | 68.34 | 70.02 | 1.017M |
| Aug 11, 2026 | 67.54 | 69.66 | 66.34 | 69.46 | 740801.0 |
| Aug 10, 2026 | 64.79 | 67.86 | 62.85 | 67.76 | 947744.0 |
| Aug 07, 2026 | 65.33 | 68.00 | 63.75 | 64.79 | 983151.0 |
| Aug 06, 2026 | 57.63 | 66.24 | 57.63 | 65.33 | 1.649M |
| Aug 05, 2026 | 62.02 | 62.02 | 60.12 | 61.29 | 354602.0 |
| Aug 04, 2026 | 61.67 | 62.18 | 60.33 | 61.11 | 541862.0 |
| Aug 03, 2026 | 59.08 | 63.00 | 58.72 | 61.32 | 831325.0 |
| Jul 31, 2026 | 58.85 | 59.33 | 57.32 | 59.04 | 637030.0 |
| Jul 30, 2026 | 57.88 | 59.75 | 57.09 | 59.54 | 699199.0 |
| Jul 29, 2026 | 58.76 | 59.40 | 57.33 | 58.52 | 679843.0 |
| Jul 28, 2026 | 60.99 | 61.36 | 58.67 | 58.95 | 510220.0 |
| Jul 27, 2026 | 58.74 | 61.21 | 58.74 | 60.12 | 725405.0 |
| Jul 24, 2026 | 58.71 | 59.06 | 57.54 | 58.66 | 446510.0 |
| Jul 23, 2026 | 56.47 | 58.58 | 56.38 | 58.58 | 1.089M |
| Jul 22, 2026 | 57.25 | 58.78 | 56.31 | 57.58 | 1.283M |
| Jul 21, 2026 | 55.24 | 57.79 | 55.24 | 57.26 | 1.043M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Structure Therapeutics, Inc. | 51.00 |
| Alumis, Inc. | 23.03 |
| Veradermics, Inc. | 99.88 |
| ANI Pharmaceuticals, Inc. | 74.23 |
| Corcept Therapeutics, Inc. | 126.20 |
Price Related Metrics
| PS Ratio | 5.213 |
| Price to Book Value | 9.188 |
| Price to Free Cash Flow | 56.44 |
| Earnings Yield | -1.47% |
| Market Cap | 3.186B |